Citizens upgrades Lyell Immunopharma stock price target on trial progress

Citizens upgrades Lyell Immunopharma stock price target on trial progress

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.